文献速递肝病消化道肿瘤与早癌消化内镜

超声造影LI-RADS LR-5在多中心回顾性研究1006个结节中识别肝硬化肝细胞癌

Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
PubMed 文献 · J Hepatol · 2017-11-11

该多中心回顾性研究纳入意大利五中心848例慢性肝病患者的1006个结节,验证超声造影LI-RADS分类对肝细胞癌的诊断价值。LR-5类别占全部结节的52%,对肝细胞癌的阳性预测值为98.5%,无纯胆管癌误诊风险,灵敏度为62%。结论认为CEUS LI-RADS LR-5对肝细胞癌高度特异,可用于自信的无创诊断。

要点

  • LR-5类别占全部结节的52%,对肝细胞癌的阳性预测值为98.5%。
  • LR-5类别无纯胆管癌误诊风险,对肝细胞癌的灵敏度为62%。
  • 超过75%的胆管癌归为LR-M,所有LR-M结节均为恶性且多数非肝细胞来源。

核心结论

  • CEUS LI-RADS LR-5类别对肝细胞癌高度特异,可用于自信的无创诊断。

研究设计与样本

  • 意大利五个中心回顾性分析848例有肝细胞癌风险的慢性肝病患者共1006个结节。
  • 结节按CEUS LI-RADS分类:LR-5为≥1 cm、动脉期高增强且晚廓清(注射造影剂后≥60秒开始)程度轻微;环状增强和/或早期和/或明显廓清定为LR-M;其他组合定为LR-3或LR-4。
  • 诊断参考标准为CT/MRI诊断肝细胞癌(n=506)或组织学(n=500)。

主要发现

  • 结节中位大小为2 cm。
  • 1006个结节中,820个(81%)为肝细胞癌,40个(4%)为胆管癌,116个(11%)为再生结节(±不典型增生)。
  • LR-5类别占全部结节的52%,对肝细胞癌的阳性预测值为98.5%,无纯胆管癌误诊风险,对肝细胞癌的灵敏度为62%。
  • 所有LR-M结节均为恶性且多数非肝细胞来源,超过75%的胆管癌归为LR-M。
  • LR-3类别包括203个病灶(其中肝细胞癌96个[47%]),LR-4类别包括202个病灶(其中肝细胞癌173个[87%])。

关键数值与推荐

  • LR-5定义:结节≥1 cm,动脉期高增强,晚廓清(注射造影剂后≥60秒开始)且程度轻微。
  • LR-M定义:环状增强和/或早期和/或明显廓清,归为恶性但非肝细胞癌特异。

临床怎么用

  • 原文结论认为CEUS LI-RADS LR-5对肝细胞癌高度特异,可用于自信的无创诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The use of contrast enhanced ultrasound (CEUS) for the diagnosis of hepatocellular carcinoma (HCC) in cirrhosis was questioned because of the risk of a false positive diagnosis in cases of cholangiocarcinoma. The American College of Radiology has recently released a scheme (CEUS Liver Imaging Reporting and Data System [LI-RADS®]) to classify lesions at risk of HCC investigated by CEUS. The aim of the present study was to validate this LI-RADS scheme for the diagnosis of HCC. METHODS: A total of 1,006 nodules from 848 patients with chronic liver disease at risk of HCC were collected in five Italian centers and retrospectively analyzed. Nodules were classified as LR-5, (HCC) if ≥1 cm with arterial phase hyperenhancement, and late washout (onset ≥60 s after contrast injection) of mild degree. Rim enhancement and/or early and/or marked washout qualified lesions as LR-M (malignant, but not specific for HCC). Other combinations qualified lesions at intermediate risk for HCC (LR-3) or probable HCC (LR-4). Diagnostic reference standard was CT/MRI diagnosis of HCC (n = 506) or histology (n = 500). RESULTS: The median nodule size was 2 cm. Of 1,006 nodules, 820 (81%) were HCC, 40 (4%) were cholangiocarcinoma, 116 (11%) regenerative nodules (±dysplastic). The LR-5 category (52% of all nodules) was 98.5% predictive of HCC, with no risk of misdiagnosis for pure cholangiocarcinoma. Sensitivity for HCC was 62%. All LR-M nodules were malignant and the majority of non-hepatocellular origin. Over 75% of cholangiocarcinomas were LR-M. The LR-3 category included 203 lesions (HCC 96 [47%]) and the LR-4 202 (HCC 173 [87%]). CONCLUSIONS: The CEUS LI-RADS class LR-5 is highly specific for HCC, enabling its use for a confident non-invasive diagnosis. LAY SUMMARY: This is a retrospective study of approximately 1,000 focal lesions at risk for hepatocellular carcinoma (HCC). Herein, we demonstrate that the refined definition of the typical contrast enhanced ultrasound pattern of HCC introduced by the Liver Imaging Reporting and Data System (LI-RADS®) practically abolishes the risk of misdiagnosis of other malignant entities (e.g. cholangiocarcinoma) for HCC with negligible reduction in sensitivity. These data support the use of contrast enhanced ultrasound to diagnose HCC in cirrhosis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Terzi E, Iavarone M, Pompili M, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. J Hepatol. 2017. PMID: 29133247. doi:10.1016/j.jhep.2017.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。